Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer

被引：0
|
作者：
Lianyuan Tao
Juntuo Zhou
Chunhui Yuan
Lingfu Zhang
Deyu Li
Dandan Si
Dianrong Xiu
Lijun Zhong
机构：
[1] Henan University,Department of Hepatobiliary Surgery, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine
[2] Peking University Third Hospital,Department of General Surgery
[3] Beihang University,Beijing Advanced Innovation Center for Big Data
[4] Peking University Health Science Center,Based Precision Medicine
[5] AB Sciex Analytical Instrument Trading Co.,Medical and Health Analytical Center
[6] Ltd. Beijing Office,undefined
来源：
Metabolomics | 2019年 / 15卷
关键词：
Pancreatic cancer; Serum exosome; Lipidomics; Exosome biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Pancreatic cancer survival prediction via inflammatory serum markers
    Mira Lanki
    Hanna Seppänen
    Harri Mustonen
    Aino Salmiheimo
    Ulf-Håkan Stenman
    Marko Salmi
    Sirpa Jalkanen
    Caj Haglund
    Cancer Immunology, Immunotherapy, 2022, 71 : 2287 - 2292
  • [42] Exosomal expression analysis of serum pancreatic cancer miRNA markers
    Ichikawa, Makiko
    Yoshioka, Yusuke
    Takayama, Aiko
    Mizoguchi, Atsuko
    Sudo, Hiroko
    Yamamoto, Yusuke
    Ochiya, Takahiro
    CANCER SCIENCE, 2018, 109 : 547 - 547
  • [43] Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk
    Shu, Xiang
    Zheng, Wei
    Yu, Danxia
    Li, Hong-Lan
    Lan, Qing
    Yang, Gong
    Cai, Hui
    Ma, Xiao
    Rothman, Nathaniel
    Gao, Yu-Tang
    Jia, Wei
    Xiang, Yong-Bing
    Shu, Xiao-Ou
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (09) : 2161 - 2167
  • [44] Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study
    Zhao, Rui
    Ren, Shuai
    Li, Changyin
    Guo, Kai
    Lu, Zipeng
    Tian, Lei
    He, Jian
    Zhang, Kai
    Cao, Yingying
    Liu, Shijia
    Li, Donghui
    Wang, Zhongqiu
    CANCER MEDICINE, 2023, 12 (04): : 5158 - 5171
  • [45] Serum metabolomics differentiating pancreatic cancer from new-onset diabetes
    He, Xiangyi
    Zhong, Jie
    Wang, Shuwei
    Zhou, Yufen
    Wang, Lei
    Zhang, Yongping
    Yuan, Yaozong
    ONCOTARGET, 2017, 8 (17) : 29116 - 29124
  • [46] PANCREATIC CANCER Exosomes for targeting KRAS in the treatment of pancreatic cancer
    Buscail, Louis
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (11) : 636 - 637
  • [47] Comparative Proteomics Analysis of Exosomes Identifies Key Pathways and Protein Markers Related to Breast Cancer Metastasis
    Shen, Shichen
    Tu, Chengjian
    Shen, He
    Li, Jun
    Frangou, Costa
    Zhang, Jianmin
    Qu, Jun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [48] Glypican-1 identifies cancer exosomes and detects early pancreatic cancer (vol 523, pg 177, 2015)
    Melo, Sonia A.
    Luecke, Linda B.
    Kahlert, Christoph
    Fernandez, Agustin F.
    Gammon, Seth T.
    Kaye, Judith
    LeBleu, Valerie S.
    Mittendorf, Elizabeth A.
    Weitz, Juergen
    Rahbari, Nuh
    Reissfelder, Christoph
    Pilarsky, Christian
    Fraga, Mario F.
    Piwnica-Worms, David
    Kalluri, Raghu
    NATURE, 2022, 610 (7932) : E15 - E17
  • [49] A Cross-Platform Metabolomics Comparison Identifies Serum Metabolite Signatures of Liver Fibrosis Progression in Chronic Hepatitis C Patients
    Shanmuganathan, Meera
    Sarfaraz, Mohammad Omair
    Kroezen, Zachary
    Philbrick, Holly
    Poon, Richel
    Don-Wauchope, Andrew
    Puglia, Marco
    Wishart, David
    Britz-McKibbin, Philip
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [50] Cancer stem cell markers and exosomes
    Heiler, S.
    Zoeller, M.
    Erb, U.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S70 - S71
12345